Nonetheless, both strategies face different disadvantages and must be balanced against individual therapies: reducing bolus and/or basal insulin and its association with hyperglycemia might imply a harmful impact on micro- and macrovascular complications [7,11,13]. Here, INS is linked to Hyperglycemia.